Hurley Capital’s Braskem BAK Stock Holding History

Hurley Capital’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-200	Closed	-$590	–	683
2025 Q4	$590	Buy	+200	New	+$548	﹤0.01%	541

Other funds holding BAK

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

XSC

X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return

LCM

Lonestar Capital Management San Francisco, California $671M AUM 72.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hurley Capital's BAK Position: Q1 2026 in Review

Hurley Capital sold out of Braskem (BAK) in Q1 2026, closing a stake of 200 shares — an estimated $590 sold.

Hurley Capital first reported a position in BAK in Q4 2025 and held it in 1 quarter. The position peaked at $590 in Q4 2025. 64 funds tracked by Wall St. Rank hold BAK as of Q1 2026.

Hurley Capital reported no remaining Braskem position as of Q1 2026 after selling out during the quarter.
Hurley Capital sold 200 Braskem shares in Q1 2026, an estimated $590.
Hurley Capital first reported a position in Braskem in Q4 2025 and held it in 1 quarter.
Hurley Capital's Braskem position peaked at $590 in Q4 2025.
64 funds tracked by Wall St. Rank held Braskem as of Q1 2026.

Based on Hurley Capital's 13F filing for Q1 2026, filed 6 May 2026.